Terms: = Bone cancer AND WHSC1, 7468, O96028, WHS, TRX5, REIIBP, NSD2, MMSET, MGC176638, KIAA1090, FLJ23286 AND Prognosis
11 results:
1. Association of whsc1/nsd2 and T-cell infiltration with prostate cancer metastasis and prognosis.
Li Q; Zhu J; Zhang Y; Pan Y; Li Z; Wang M; Gao Y; Feng D; He X; Zhang C
Sci Rep; 2023 Dec; 13(1):21629. PubMed ID: 38062230
[TBL] [Abstract] [Full Text] [Related]
2. Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma.
Jakubikova J; Cholujova D; Beke G; Hideshima T; Klucar L; Leiba M; Jamroziak K; Richardson PG; Kastritis E; Dorfman DM; Anderson KC
JCI Insight; 2023 Feb; 8(3):. PubMed ID: 36752202
[TBL] [Abstract] [Full Text] [Related]
3. Plasma cell neoplasms and related entities-evolution in diagnosis and classification.
Fend F; Dogan A; Cook JR
Virchows Arch; 2023 Jan; 482(1):163-177. PubMed ID: 36414803
[TBL] [Abstract] [Full Text] [Related]
4. Posttranslational modification of Aurora A-nsd2 loop contributes to drug resistance in t(4;14) multiple myeloma.
Jiang H; Wang Y; Wang J; Wang Y; Wang S; He E; Guo J; Xie Y; Wang J; Li X; Peng Z; Wang M; Hou J; Liu Z
Clin Transl Med; 2022 Apr; 12(4):e744. PubMed ID: 35389552
[TBL] [Abstract] [Full Text] [Related]
5. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.
Hill HA; Qi X; Jain P; Nomie K; Wang Y; Zhou S; Wang ML
Blood Adv; 2020 Jul; 4(13):2927-2938. PubMed ID: 32598477
[TBL] [Abstract] [Full Text] [Related]
6. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N
J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188
[TBL] [Abstract] [Full Text] [Related]
7. [Application of FICTION technique to the detection of genetic aberrations in multiple myeloma].
Wang D; Huang L; Zhang H; Geng Z; Shang Z; Zhou JF; Li CR
Zhonghua Xue Ye Xue Za Zhi; 2011 Apr; 32(4):226-30. PubMed ID: 21569703
[TBL] [Abstract] [Full Text] [Related]
8. Microfluidic chips for detecting the t(4;14) translocation and monitoring disease during treatment using reverse transcriptase-polymerase chain reaction analysis of IgH-mmset hybrid transcripts.
VanDijken J; Kaigala GV; Lauzon J; Atrazhev A; Adamia S; Taylor BJ; Reiman T; Belch AR; Backhouse CJ; Pilarski LM
J Mol Diagn; 2007 Jul; 9(3):358-67. PubMed ID: 17591936
[TBL] [Abstract] [Full Text] [Related]
9. Early genetic events provide the basis for a clinical classification of multiple myeloma.
Kuehl WM; Bergsagel PL
Hematology Am Soc Hematol Educ Program; 2005; ():346-52. PubMed ID: 16304402
[TBL] [Abstract] [Full Text] [Related]
10. Molecular pathogenesis and a consequent classification of multiple myeloma.
Bergsagel PL; Kuehl WM
J Clin Oncol; 2005 Sep; 23(26):6333-8. PubMed ID: 16155016
[TBL] [Abstract] [Full Text] [Related]
11. Advances in biology of multiple myeloma: clinical applications.
Hideshima T; Bergsagel PL; Kuehl WM; Anderson KC
Blood; 2004 Aug; 104(3):607-18. PubMed ID: 15090448
[TBL] [Abstract] [Full Text] [Related]